Form D · Biotechnology

Tempo Therapeutics, Inc.

San Diego, CA · CIK 0001813688

Offering snapshot reported Sep 11, 2026 · SEC filing

Reported sold
$14M
Offering amount: $14.5M
Investors reported
43
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 27, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 11, 2026Initial$14,000,000No comparison43SEC filing
Mar 15, 2024Initial$16,327,664No comparison26SEC filing
Aug 9, 2021Amendment$3,844,046No comparisonNot reportedSEC filing
Jun 2, 2020Initial$3,844,046No comparison39SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-597176

Source: Form D, filed Sep 11, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dino Di Carlo Director
Donald Griffin Director
Richard Hancock Director
Biren Mehta Director
Steven Richieri Director
Eric Richman Director, Executive
Steven Sands Director
Robin Sitver Director
Westbrook Weaver Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3030 Bunker Hill Street Suite 308
San Diego, CA, 92109
Phone: 6192027445